Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
140 participants
INTERVENTIONAL
2024-09-10
2028-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• How does the combination of behavioral intervention and technology influence weight loss in young adults?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing Intervention Strategies for Addressing Obesity and Binge Eating
NCT04771455
Innovative Approaches to Diet, Exercise and Activity
NCT01131871
Novel Executive Function Training for Obesity
NCT03724396
Recruiting and Retaining Young Adults in Behavioral Weight Loss Treatment
NCT01889082
Weight Management Skills in African American Outpatients
NCT00146081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lifestyle Intervention
Diet and exercise coaching
Lifestyle
All participants will receive diet and exercise goals and coaching.
Lifestyle Intervention II
Diet and exercise coaching
Lifestyle II
All participants will receive diet and exercise goals and coaching.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle
All participants will receive diet and exercise goals and coaching.
Lifestyle II
All participants will receive diet and exercise goals and coaching.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18 to 40 years
* Weight stable (no change \>25 lbs in the past 3 months)
* Owns a smartphone and willing to install the study app
Exclusion Criteria
* Irregular menses, menopausal symptoms or post-menopausal, currently pregnant, trying to get pregnant or nursing
* Regular travel across time zones
* Subjects who are currently following a weight loss regimen or any other special diet or exercise programs
* Increased fractional lean body mass (e.g., athletes)
* Unable to walk, using an assistive device for mobility, or any contraindications to exercise
* Diabetes
* Claustrophobia
* Excessive alcohol (\>2 drinks/day) or caffeine (\>300mg/day) intake, regular nicotine use, substance abuse.
* Abnormal findings on screening blood testing.
* Participants taking any prescription, over-the-counter drugs/supplements that can affect sleep or weight.
* Major psychiatric or any eating disorder, and any acute or chronic medical condition that increase the risk of interventions (e.g., heart disease)
* Any underlying disease likely to limit life span and/or increase risk of interventions including cardiovascular disease (e.g. unstable angina, heart failure requiring hospitalization in the past 6 months, significant heart block or arrhythmias, NYHA Class\>2), pulmonary disease with dependence on oxygen or daily use of bronchodilators, cancer requiring treatment in the past 5 years unless the prognosis is considered good, active or chronic infection, thyroid disease and other endocrine disorders (e.g. Cushing syndrome, acromegaly), hepatitis or other chronic gastrointestinal disease (pancreatitis, inflammatory bowel disease), renal disease, significant anemia, recent surgery or significant abdominal surgery, major psychiatric or any eating disorder, acute coronary syndrome or stroke in the past 6 months
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esra Tasali, MD
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
UChicago IRB
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB23-1677
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.